High-throughput transcriptomics has evolved from bulk RNA-seq to single-cell and spatial profiling,yet its clinical translation still depends on effective integration across diverse omics and data modalities.Emerging ...High-throughput transcriptomics has evolved from bulk RNA-seq to single-cell and spatial profiling,yet its clinical translation still depends on effective integration across diverse omics and data modalities.Emerging foundation models and multimodal learning frameworks are enabling scalable and transferable representations of cellular states,while advances in interpretability and real-world data integration are bridging the gap between discovery and clinical application.This paper outlines a concise roadmap for AI-driven,transcriptome-centered multi-omics integration in precision medicine(Figure 1).展开更多
The discovery of new superconducting materials,particularly those exhibiting high critical temperature(Tc),has been a vibrant area of study within the field of condensed matter physics.Conventional approaches primaril...The discovery of new superconducting materials,particularly those exhibiting high critical temperature(Tc),has been a vibrant area of study within the field of condensed matter physics.Conventional approaches primarily rely on physical intuition to search for potential superconductors within the existing databases.However,the known materials only scratch the surface of the extensive array of possibilities within the realm of materials.展开更多
Introduction Early cancer detection represents a critical evolution in healthcare,addressing a significant pain point in cancer treatment:the tendency for diagnoses to occur at advanced stages.Traditionally,many cance...Introduction Early cancer detection represents a critical evolution in healthcare,addressing a significant pain point in cancer treatment:the tendency for diagnoses to occur at advanced stages.Traditionally,many cancers are not identified until they have progressed to late stages,where treatment options become limited,less effective,and more costly.This late detection results in poorer prognoses,higher mortality rates,and increased healthcare costs.Without early detection tools like Fluorescence In Situ Hybridization(FISH),these challenges persist,leaving patients with fewer opportunities for successful outcomes.展开更多
Additive Manufacturing(AM)has significantly impacted the development of high-performance materials and structures,offering new possibilities for industries ranging from aerospace to biomedicine.This special issue feat...Additive Manufacturing(AM)has significantly impacted the development of high-performance materials and structures,offering new possibilities for industries ranging from aerospace to biomedicine.This special issue features pioneering research that integrates AI-driven methods with AM,enabling the design and fabrication of complex,optimized structures with enhanced properties.展开更多
AI is revolutionizing the current paradigm of pharmaceutical research,addressing the challenges encountered at all stages of the process.AI driven drug discovery is based on biomedical big data and new algorithms to i...AI is revolutionizing the current paradigm of pharmaceutical research,addressing the challenges encountered at all stages of the process.AI driven drug discovery is based on biomedical big data and new algorithms to identify drug targets,screen and optimize active compounds,analyze drug properties,and facilitate drug production and quality control.On this basis,we organized this special issue entitled"Innovative Pharmaceutical Research Driven by AI",and collected Original research articles,Reviewpapers.展开更多
文摘High-throughput transcriptomics has evolved from bulk RNA-seq to single-cell and spatial profiling,yet its clinical translation still depends on effective integration across diverse omics and data modalities.Emerging foundation models and multimodal learning frameworks are enabling scalable and transferable representations of cellular states,while advances in interpretability and real-world data integration are bridging the gap between discovery and clinical application.This paper outlines a concise roadmap for AI-driven,transcriptome-centered multi-omics integration in precision medicine(Figure 1).
基金financially supported by the National Natural Science Foundation of China(Grant Nos.62476278,12434009,and 12204533)the National Key R&D Program of China(Grant No.2024YFA1408601)the Innovation Program for Quantum Science and Technology(Grant No.2021ZD0302402)。
文摘The discovery of new superconducting materials,particularly those exhibiting high critical temperature(Tc),has been a vibrant area of study within the field of condensed matter physics.Conventional approaches primarily rely on physical intuition to search for potential superconductors within the existing databases.However,the known materials only scratch the surface of the extensive array of possibilities within the realm of materials.
基金supported by Guangzhou Development Zone Science and Technology(2021GH10,2020GH10,2023GH02)the University of Macao(MYRG2022-00271-FST)The Science and Technology Development Fund(FDCT)of Macao(0032/2022/A).
文摘Introduction Early cancer detection represents a critical evolution in healthcare,addressing a significant pain point in cancer treatment:the tendency for diagnoses to occur at advanced stages.Traditionally,many cancers are not identified until they have progressed to late stages,where treatment options become limited,less effective,and more costly.This late detection results in poorer prognoses,higher mortality rates,and increased healthcare costs.Without early detection tools like Fluorescence In Situ Hybridization(FISH),these challenges persist,leaving patients with fewer opportunities for successful outcomes.
文摘Additive Manufacturing(AM)has significantly impacted the development of high-performance materials and structures,offering new possibilities for industries ranging from aerospace to biomedicine.This special issue features pioneering research that integrates AI-driven methods with AM,enabling the design and fabrication of complex,optimized structures with enhanced properties.
文摘AI is revolutionizing the current paradigm of pharmaceutical research,addressing the challenges encountered at all stages of the process.AI driven drug discovery is based on biomedical big data and new algorithms to identify drug targets,screen and optimize active compounds,analyze drug properties,and facilitate drug production and quality control.On this basis,we organized this special issue entitled"Innovative Pharmaceutical Research Driven by AI",and collected Original research articles,Reviewpapers.
